Skip to main content
All lobbying filings

Federal Health Policy Strategies

Federal Health Policy Strategies filed a Q3 report for Fresenius Medical Care North America on October 20, 2026, reporting $60,000 in lobbying income.

Lobbying for Fresenius Medical Care North America · Provider of dialysis products

As filed: FEDERAL HEALTH POLICY STRATEGIES for FRESENIUS MEDICAL CARE NORTH AMERICA.

All filings by Federal Health Policy Strategies · Everything Fresenius Medical Care North America has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Issues impacting coverage of end-stage renal disease.

Issues impacting coverage of end-stage renal disease.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem